Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy

Lota, Amrit S., Hazebroek, Mark R., Theotokis, Pantazis, Wassall, Rebecca, Salmi, Sara, Halliday, Brian P., Tayal, Upasana, Verdonschot, Job, Meena, Devendra, Owen, Ruth, de Marvao, Antonio, Iacob, Alma, Yazdani, Momina, Hammersley, Daniel J., Jones, Richard E., Wage, Riccardo, Buchan, Rachel, Vivian, Fredrik, Hafouda, Yakeen, Noseda, Michela, Gregson, John, Mittal, Tarun, Wong, Joyce, Robertus, Jan Lukas, Baksi, A. John, Vassiliou, Vassilios S. ORCID:, Tzoulaki, Ioanna, Pantazis, Antonis A., Cleland, John G. F., Barton, Paul J. R., Cook, Stuart A., Pennell, Dudley J., Garcia-Pavia, Pablo, Cooper Jr, Leslie T., Heymans, Stephane, Ware, James S. and Prasad, Sanjay K. (2022) Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation. ISSN 0009-7322

[thumbnail of Genetic determinants of myocarditis Lota et al CIRC v3 29_06_22 - Accepted] PDF (Genetic determinants of myocarditis Lota et al CIRC v3 29_06_22 - Accepted) - Accepted Version
Restricted to Repository staff only until 26 March 2023.

Request a copy


Background: Acute myocarditis is an inflammatory condition that may herald the onset of dilated cardiomyopathy (DCM) or arrhythmogenic cardiomyopathy (ACM). We investigated the frequency and clinical consequences of DCM and ACM genetic variants in a population-based cohort of patients with acute myocarditis. Methods: This was a population-based cohort of 336 consecutive patients with acute myocarditis enrolled in London and Maastricht. All participants underwent targeted DNA sequencing for well-characterized cardiomyopathy-associated genes with comparison to healthy controls (n=1053) sequenced on the same platform. Case ascertainment in England was assessed against national hospital admission data. The primary outcome was all-cause mortality. Results: Variants that would be considered pathogenic if found in a patient with DCM or ACM were identified in 8% of myocarditis cases compared with <1% of healthy controls (P=0.0097). In the London cohort (n=230; median age, 33 years; 84% men), patients were representative of national myocarditis admissions (median age, 32 years; 71% men; 66% case ascertainment), and there was enrichment of rare truncating variants (tv) in ACM-associated genes (3.1% of cases versus 0.4% of controls; odds ratio, 8.2; P=0.001). This was driven predominantly by DSP-tv in patients with normal LV ejection fraction and ventricular arrhythmia. In Maastricht (n=106; median age, 54 years; 61% men), there was enrichment of rare truncating variants in DCM-associated genes, particularly TTN-tv, found in 7% (all with left ventricular ejection fraction<50%) compared with 1% in controls (odds ratio, 3.6; P=0.0116). Across both cohorts over a median of 5.0 years (interquartile range, 3.9–7.8 years), all-cause mortality was 5.4%. Two-thirds of deaths were cardiovascular, attributable to worsening heart failure (92%) or sudden cardiac death (8%). The 5-year mortality risk was 3.3% in genotype-negative patients versus 11.1% for genotype-positive patients (Padjusted=0.08). Conclusions: We identified DCM- or ACM-associated genetic variants in 8% of patients with acute myocarditis. This was dominated by the identification of DSP-tv in those with normal left ventricular ejection fraction and TTN-tv in those with reduced left ventricular ejection fraction. Despite differences between cohorts, these variants have clinical implications for treatment, risk stratification, and family screening. Genetic counseling and testing should be considered in patients with acute myocarditis to help reassure the majority while improving the management of those with an underlying genetic variant.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 20 Jul 2022 16:30
Last Modified: 06 Oct 2022 10:30
DOI: 10.1161/CIRCULATIONAHA.121.058457

Actions (login required)

View Item View Item